Literature DB >> 19793828

The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model.

Min-Suk Song1, Philippe Noriel Q Pascua, Jun Han Lee, Yun Hee Baek, Ok-Jun Lee, Chul-Joong Kim, Hyunggee Kim, Richard J Webby, Robert G Webster, Young Ki Choi.   

Abstract

Adaptation of influenza A viruses to a new host species usually involves the mutation of one or more of the eight viral gene segments, and the molecular basis for host range restriction is still poorly understood. To investigate the molecular changes that occur during adaptation of a low-pathogenic avian influenza virus subtype commonly isolated from migratory birds to a mammalian host, we serially passaged the avirulent wild-bird H5N2 strain A/Aquatic bird/Korea/W81/05 (W81) in the lungs of mice. The resulting mouse-adapted strain (ma81) was highly virulent (50% mouse lethal dose = 2.6 log(10) 50% tissue culture infective dose) and highly lethal. Nonconserved mutations were observed in six viral genes (those for PB2, PB1, PA, HA, NA, and M). Reverse genetic experiments substituting viral genes and mutations demonstrated that the PA gene was a determinant of the enhanced virulence in mice and that a Thr-to-Iso substitution at position 97 of PA played a key role. In growth kinetics studies, ma81 showed enhanced replication in mammalian but not avian cell lines; the PA(97I) mutation in strain W81 increased its replicative fitness in mice but not in chickens. The high virulence associated with the PA(97I) mutation in mice corresponded to considerably enhanced polymerase activity in mammalian cells. Furthermore, this characteristic mutation is not conserved among avian influenza viruses but is prevalent among mouse-adapted strains, indicating a host-dependent mutation. To our knowledge, this is the first study that the isoleucine residue at position 97 in PA plays a key role in enhanced virulence in mice and is implicated in the adaptation of avian influenza viruses to mammalian hosts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793828      PMCID: PMC2786751          DOI: 10.1128/JVI.01373-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

2.  Changes of morphological, biological and antigenic properties of avian influenza A virus haemagglutinin H2 in the course of adaptation to new host.

Authors:  A S Lipatov; A K Gitelman; E A Govorkova
Journal:  Acta Virol       Date:  1995-12       Impact factor: 1.162

3.  Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8.

Authors:  E G Brown
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth.

Authors:  C A Smeenk; E G Brown
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis.

Authors:  J J Sanz-Ezquerro; T Zürcher; S de la Luna; J Ortín; A Nieto
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  [Changes in its hemagglutinin during the adaptation of the influenza virus to mice and their role in the acquisition of virulent properties and resistance to serum inhibitors].

Authors:  A A Shilov; B V Sinitsyn
Journal:  Vopr Virusol       Date:  1994 Jul-Aug

7.  Circulation of influenza viruses and paramyxoviruses in waterfowl originating from two different areas of North America.

Authors:  V S Hinshaw; J M Wood; R G Webster; R Deibel; B Turner
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

8.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range.

Authors:  E K Subbarao; W London; B R Murphy
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Studies on the genetic determinants of influenza virus pathogenicity for mice with the use of reassortants between mouse-adapted and non-adapted variants of the same virus strain.

Authors:  I A Rudneva; N V Kaverin; N L Varich; A K Gitelman; A M Makhov; S M Klimenko; V M Zhdanov
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

10.  Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico.

Authors:  T Horimoto; E Rivera; J Pearson; D Senne; S Krauss; Y Kawaoka; R G Webster
Journal:  Virology       Date:  1995-10-20       Impact factor: 3.616

View more
  86 in total

1.  Emergence of mammalian species-infectious and -pathogenic avian influenza H6N5 virus with no evidence of adaptation.

Authors:  Jeong-Hyun Nam; Eun-Ha Kim; Daesub Song; Young Ki Choi; Jeong-Ki Kim; Haryoung Poo
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

2.  Growth and Pathogenic Potential of Naturally Selected Reassortants after Coinfection with Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Viruses.

Authors:  Min-Suk Song; Yun Hee Baek; Philippe Noriel Q Pascua; Hyeok-Il Kwon; Eun-Ha Kim; Su-Jin Park; Se Mi Kim; Young-Il Kim; Won-Suk Choi; Eung-Gook Kim; Chul-Joong Kim; Young Ki Choi
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

3.  Multiple amino acid substitutions involved in the adaption of three avian-origin H7N9 influenza viruses in mice.

Authors:  Jianru Qin; Ouyang Peng; Xiaoting Shen; Lang Gong; Chunyi Xue; Yongchang Cao
Journal:  Virol J       Date:  2019-01-08       Impact factor: 4.099

4.  Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.

Authors:  Moon Cheol Kang; Dong-Hoon Choi; Young Woo Choi; Seong Jeong Park; Hong Namkoong; Ki Seok Park; So-Shin Ahn; Charles D Surh; Sun-Woo Yoon; Doo-Jin Kim; Jung-ah Choi; Yunji Park; Young Chul Sung; Seung-Woo Lee
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

5.  Mammalian adaptive mutations of the PA protein of highly pathogenic avian H5N1 influenza virus.

Authors:  Reina Yamaji; Shinya Yamada; Mai Q Le; Mutsumi Ito; Yuko Sakai-Tagawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

6.  Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.

Authors:  Se Mi Kim; Young-Il Kim; Su-Jin Park; Eun-Ha Kim; Hyeok-Il Kwon; Young-Jae Si; In-Won Lee; Min-Suk Song; Young Ki Choi
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

7.  PA residues in the 2009 H1N1 pandemic influenza virus enhance avian influenza virus polymerase activity in mammalian cells.

Authors:  Kendra A Bussey; Emily A Desmet; Jonelle L Mattiacio; Alice Hamilton; Birgit Bradel-Tretheway; Howard E Bussey; Baek Kim; Stephen Dewhurst; Toru Takimoto
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

8.  Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence.

Authors:  Gongxun Zhong; Mai Quynh Le; Tiago J S Lopes; Peter Halfmann; Masato Hatta; Shufang Fan; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

9.  The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice.

Authors:  Jiao Hu; Zenglei Hu; Qingqing Song; Min Gu; Xiaowen Liu; Xiaoquan Wang; Shunlin Hu; Chaoyang Chen; Huimou Liu; Wenbo Liu; Sujuan Chen; Daxin Peng; Xiufan Liu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 10.  Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier.

Authors:  Benjamin Mänz; Martin Schwemmle; Linda Brunotte
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.